Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-08

Clinical Trial Update: Tachosil for the Prevention of Symptomatic Lymph Cysts [Phase 3]

View source ↗

Summary

Phase 3 trial update on Tachosil for prevention of symptomatic lymph cysts in gynecologic cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TachoSil (fibrin sealant patch)

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Endometrial Cancer, Cervical Cancer | Phase 3 | Status: COMPLETED